8 insiders reported 22 Form 4 transactions for FATE THERAPEUTICS INC (FATE) over the past 18 months (most recent 2026-08-05). Recent activity: TAHL CINDY (See Remarks) Sell 38,800 shares, Valamehr Bahram (President and CEO) Sell 43,947 shares, TAHL CINDY (See Remarks) Sell 25,590 shares, Valamehr Bahram (President and CEO) Sell 28,946 shares, TAHL CINDY (See Remarks) Buy 122,220 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | TAHL CINDY | See Remarks | Sell | 38,800 | $95,405 |
| 2026-08-05 | Valamehr Bahram | President and CEO | Sell | 43,947 | $108,101 |
| 2026-05-21 | TAHL CINDY | See Remarks | Sell | 25,590 | $48,084 |
| 2026-05-21 | Valamehr Bahram | President and CEO | Sell | 28,946 | $54,482 |
| 2026-05-07 | TAHL CINDY | See Remarks | Buy | 122,220 | $161,330 |
| 2026-05-07 | TAHL CINDY | See Remarks | Buy | 44,444 | $46,666 |
| 2026-05-06 | RASTETTER WILLIAM H | Director | Buy | 25,000 | $42,250 |
| 2026-05-06 | EPSTEIN ROBERT S | Director | Buy | 25,000 | $42,250 |
| 2026-04-22 | Redmile Group, LLC | Director | Sell | 9.0M | $0 |
| 2026-04-22 | Green Jeremy | Director | Sell | 9.0M | $0 |
| 2026-04-22 | RedCo II Master Fund, L.P. | Director | Sell | 9.0M | $0 |
| 2026-04-22 | Redmile Group, LLC | Director | Buy | 9.0M | $0 |
| 2026-04-22 | Green Jeremy | Director | Buy | 9.0M | $0 |
| 2026-04-22 | RedCo II Master Fund, L.P. | Director | Buy | 9.0M | $0 |
| 2026-01-16 | Valamehr Bahram | President and CEO | Buy | 335,000 | $0 |
| 2026-01-16 | TAHL CINDY | See Remarks | Buy | 100,000 | $0 |
| 2026-01-16 | Adawi Kamal | Chief Financial Officer | Buy | 25,000 | $0 |
| 2026-01-12 | Valamehr Bahram | President and CEO | Sell | 5,190 | $5,553 |
| 2026-01-12 | TAHL CINDY | See Remarks | Sell | 10,589 | $11,224 |
| 2025-10-21 | Adawi Kamal | Chief Financial Officer | Buy | 75,000 | $0 |
| 2025-08-05 | Valamehr Bahram | President and CEO | Sell | 14,466 | $15,334 |
| 2025-08-05 | TAHL CINDY | See Remarks | Sell | 9,037 | $9,579 |
Source: SEC Form 4 filings · as of 2026-08-05